Bio-Gene Technology Limited (ASX:BGT)
Australia flag Australia · Delayed Price · Currency is AUD
0.0370
+0.0020 (5.71%)
Mar 4, 2026, 1:09 PM AEST

Bio-Gene Technology Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
1.081.142.212.996.343.93
Cash & Short-Term Investments
1.081.142.212.996.343.93
Cash Growth
-19.21%-48.48%-26.11%-52.84%61.24%-28.77%
Accounts Receivable
-----0.02
Other Receivables
0.030.470.520.450.440.5
Receivables
0.030.470.520.450.440.52
Prepaid Expenses
-0.290.130.070.150.13
Other Current Assets
0.210.070.070.070.070.07
Total Current Assets
1.321.972.943.5874.66
Property, Plant & Equipment
0.010.010.020.010.020.02
Other Intangible Assets
0.150.170.20.240.280.31
Total Assets
1.472.153.163.847.35
Accounts Payable
0.150.080.050.120.220.09
Accrued Expenses
0.160.290.260.460.410.18
Other Current Liabilities
-0.140.04-0.380.32
Total Current Liabilities
0.310.510.350.571.010.59
Pension & Post-Retirement Benefits
00.010.020.040.030.01
Other Long-Term Liabilities
-----0.15
Total Liabilities
0.310.520.370.611.030.75
Common Stock
23.8922.9421.5219.5519.5515.06
Retained Earnings
-23.24-22.03-19.64-17.43-14.5-11.68
Comprehensive Income & Other
0.530.710.911.111.220.86
Shareholders' Equity
1.171.632.793.226.274.25
Total Liabilities & Equity
1.472.153.163.847.35
Net Cash (Debt)
1.081.142.212.996.343.93
Net Cash Growth
-19.21%-48.48%-26.11%-52.84%61.24%-28.62%
Net Cash Per Share
0.000.010.010.020.040.03
Filing Date Shares Outstanding
305.06305.06201.36177.91179.06153.63
Total Common Shares Outstanding
305.06266.42201.36177.91179.06153.63
Working Capital
1.011.462.593.015.994.07
Book Value Per Share
0.000.010.010.020.040.03
Tangible Book Value
1.021.462.592.985.993.93
Tangible Book Value Per Share
0.000.010.010.020.030.03
Machinery
-0.060.060.050.05-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.